EXTRAVASATION OF ANTHRACYCLINES

Andoh, et al., Catalytic Inhibitors DNA topoisomerase II, Biochimica et Biophysica Acta, vol. 1400, pp. 155-171, 1998. Averbuch, et al., Doxorubicin-Induced Skin Necrosis in the Swine Model: Protection With a Novel Radical Dimer, Journal of Clinical Oncology, vol. 4, No. 1, pp. 88-94, Jan., 1986. Banerjee, et al., Cancer ChemOtherapy agent-induced perivenous extravasation injuries, Postgraduate Medical Journal, vol. 63, pp. 5-9, 1987. Bekerecioglu, et al., Prevention of Adriamycin-Induced Skin Necrosis With Various Free Radical Scavengers, Journal of Surgical Research, vol. 75, pp. 61-65, 1998. Berger, et al., Structure and mechanism of DNA topoi Somerase II, Nature, vol. 379, pp. 225-232, Jan. 1996. Bleicher, et al., The Delineation of Adriamycin Extravasa tion. Using Fluorescence Microscopy, Plastic And Recon structive Surgery, vo. 74, No. 1, pp. 114-116, Jul. 1984. Brothers, et al., Experience with Subcutaneous Infusion Ports in Three Hundred Patients, Surgery, Gynecology & Obstetrics, vol. 166, No. 4, pp. 295-301, Apr. 1988. Chen. et al., DNA Topoisomerases: Essential Enzymes and Lethal Targets, Annu. Rev. Pharmacol. Toxicol. , vol. 34, pp. 191-218, 1994. Dahlström, et al., Fluorescence Microscopic Demonstration and Demarcation of Doxorubicin Extravasation, Cancer, vol. 65, No. 8, pp. 1722–1726, Apr. 15, 1990. Bartkowski-Dodds, et al., Use of Sodium Bicarbonate as a Means of Ameliorating Doxorubicin-induced Dermal Necrosis in Rats, Cancer Chemother. Pharmacol. , vol. 4, pp. 179-181, 1980. Disa, et al., Prevention of Adriamycin-Induced Full-Thick neSS Skin LOSS Using Hyaluronidase Infiltration, Plastic and Reconstructive Surgery, vol. 101, No. 2, pp. 370-374, Feb. 1993. Dorr, et al., Cold Protection and Heat Enhancement of Doxorubicin Skin Toxicity in the Mouse, Cancer Treatment Reports, vol. 69, No. 4 pp. 431–437, Apr. 1985. Dorr, et al., Failure of DMSO and Vitamin E to Prevent Doxorubicin Skin Ulceration in the Mouse, Cancer Treat ment Reports, vol. 67, No. 5, pp. 499-501, May 1983. Dorr, et al., Modulation of Experimental Doxorubicin Skin Toxicity by B-Adrenergic Compounds, Cancer Research, vol. 41, pp. 2428-2431, Jun. 1981. Dorr, et al., The Limited Role of Corticosteroids in Amelio rating Experimental Doxorubicin Skin Toxicity in the Mouse, Cancer Chemother. Pharmacol. , vol. 5, pp. 17-20, 1980. Froelich-Ammon, et al., Topoisomerase Poisons. Harness ing the Dark Side of Enzyme Mechanism, The Journal of Biological Chemistry, vol. 270, No. 37, pp. 21429-21432, Sep.1995. Hasinoff, The iron (III) and copper(II) complexes of adria mycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)pro pane) Agents And Actions, vol. 29, pp. 374-381, 19990. Herman, et al., Biological Properties of ICRF-159 and Related Bis(dioxopiperazine) Compounds, Advances In Pharmacology And Chemotherapy, vol. 19, pp. 249-290, 1982. Herman, et al., Comparison of the Protective Effect of ICRF-187 and Structurally Related Analogues Against Acute Daunorubicin Toxicity in Syrian Golden Hamsters, Research Communications. In Chemical Pathology And Pharmacology, vol. 48, No. 1, pp. 39-55, Apr. 1985.